Etihad Airways uses coronarvirus risk tool from the Viennese startup Medicus AI

© Etihad Airways: New COVID-19 tool developed by the Viennese startup Medicus AI

A risk assessment tool developed by the Viennese medical technology startup Medicus AI is now being used within the context of a partnership with the airline Etihad Airways. 22 questions should be answered by passengers of the airline Etihad Airways from the United Arab Emirates before they begin their journeys.

The assessment tool should take five minutes. This self-testing tool is designed to enable a relatively accurate assessment of the risk of a potential infection with COVID-19 by the passengers. The technology for this test is provided by the Viennese medtech startup Medicus AI.

Medicus AI launched the world's first coronavirus App certified as a medical product in cooperation with the Luxembourg-based company BioneXt Lab. The tool is now being used in partnership with Etihad and has been integrated into this App. It functions on the basis of criteria specified by the World Health Organisation WHO and is updated daily. It is available in English for the time being and will be successively expanded to enable testing in Arabic, French, German and Portuguese.
Frank Meyer, Chief Digital Officer, Etihad Airways, said: "We know that health and wellbeing will be a major factor impacting the travel decisions of our guests and are committed to ensuring their continued safety and peace of mind." The partnership with Medicus AI is one of the possibilities to adapt operations to the new demands placed on the travel industry as a result of COVID-19.

Read more here about COVID-19 research projects in Austria.